Jacob Hope

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameJacob Hope
Drug Alias Namestem cell inhibitors (Novogen)Stem Cell Inhibitors (Novogen)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionStem cells inhibitorsNeuroprotectants
TargetsUpdating
Therapy Area/IndicationsNerve DegenerationAutoimmune DiseasesGenetic Diseases, Inborn +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustralia and New Zealand
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesKazia Therapeutics Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesKazia Therapeutics Ltd
Active IndicationsN/A
Inactive IndicationsNerve DegenerationAutoimmune DiseasesGenetic Diseases, Inborn +[4] 

Other Information

ATC CodeN/A
Related LinksN/A